Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 1.34
NYSE:VAR's Cash to Debt is ranked lower than
56% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. NYSE:VAR: 1.34 )
Ranked among companies with meaningful Cash to Debt only.
NYSE:VAR' s Cash to Debt Range Over the Past 10 Years
Min: 0.24  Med: 4.05 Max: N/A
Current: 1.34
Equity to Asset 0.47
NYSE:VAR's Equity to Asset is ranked lower than
69% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. NYSE:VAR: 0.47 )
Ranked among companies with meaningful Equity to Asset only.
NYSE:VAR' s Equity to Asset Range Over the Past 10 Years
Min: 0.32  Med: 0.52 Max: 0.6
Current: 0.47
0.32
0.6
Interest Coverage 37.89
NYSE:VAR's Interest Coverage is ranked lower than
58% of the 221 Companies
in the Global Medical Devices industry.

( Industry Median: 97.42 vs. NYSE:VAR: 37.89 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:VAR' s Interest Coverage Range Over the Past 10 Years
Min: 37.89  Med: 100.85 Max: 226.41
Current: 37.89
37.89
226.41
F-Score: 6
Z-Score: 4.40
M-Score: -2.44
WACC vs ROIC
8.11%
22.10%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 14.66
NYSE:VAR's Operating margin (%) is ranked higher than
82% of the 299 Companies
in the Global Medical Devices industry.

( Industry Median: 2.42 vs. NYSE:VAR: 14.66 )
Ranked among companies with meaningful Operating margin (%) only.
NYSE:VAR' s Operating margin (%) Range Over the Past 10 Years
Min: 14.66  Med: 20.48 Max: 22.67
Current: 14.66
14.66
22.67
Net-margin (%) 10.35
NYSE:VAR's Net-margin (%) is ranked higher than
77% of the 299 Companies
in the Global Medical Devices industry.

( Industry Median: 1.92 vs. NYSE:VAR: 10.35 )
Ranked among companies with meaningful Net-margin (%) only.
NYSE:VAR' s Net-margin (%) Range Over the Past 10 Years
Min: 10.35  Med: 14.03 Max: 15.36
Current: 10.35
10.35
15.36
ROE (%) 19.69
NYSE:VAR's ROE (%) is ranked higher than
88% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 1.20 vs. NYSE:VAR: 19.69 )
Ranked among companies with meaningful ROE (%) only.
NYSE:VAR' s ROE (%) Range Over the Past 10 Years
Min: 19.69  Med: 27.57 Max: 31.67
Current: 19.69
19.69
31.67
ROA (%) 8.85
NYSE:VAR's ROA (%) is ranked higher than
82% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 0.07 vs. NYSE:VAR: 8.85 )
Ranked among companies with meaningful ROA (%) only.
NYSE:VAR' s ROA (%) Range Over the Past 10 Years
Min: 8.85  Med: 14.94 Max: 16.54
Current: 8.85
8.85
16.54
ROC (Joel Greenblatt) (%) 56.99
NYSE:VAR's ROC (Joel Greenblatt) (%) is ranked higher than
89% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 3.61 vs. NYSE:VAR: 56.99 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
NYSE:VAR' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 56.99  Med: 95.9 Max: 112.94
Current: 56.99
56.99
112.94
Revenue Growth (3Y)(%) 7.80
NYSE:VAR's Revenue Growth (3Y)(%) is ranked higher than
67% of the 224 Companies
in the Global Medical Devices industry.

( Industry Median: 3.80 vs. NYSE:VAR: 7.80 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
NYSE:VAR' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -22.2  Med: 11.8 Max: 17.4
Current: 7.8
-22.2
17.4
EBITDA Growth (3Y)(%) 3.00
NYSE:VAR's EBITDA Growth (3Y)(%) is ranked lower than
51% of the 193 Companies
in the Global Medical Devices industry.

( Industry Median: 4.10 vs. NYSE:VAR: 3.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
NYSE:VAR' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -22.2  Med: 13.9 Max: 65.2
Current: 3
-22.2
65.2
EPS Growth (3Y)(%) 1.70
NYSE:VAR's EPS Growth (3Y)(%) is ranked lower than
51% of the 190 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. NYSE:VAR: 1.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
NYSE:VAR' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -23.5  Med: 15.5 Max: 113.8
Current: 1.7
-23.5
113.8
GuruFocus has detected 4 Warning Signs with Varian Medical Systems Inc $NYSE:VAR.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:VAR's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

VAR Guru Trades in Q1 2016

Leucadia National 3,900 sh (New)
Joel Greenblatt 253,227 sh (+4147.35%)
First Eagle Investment 3,197,123 sh (+144.88%)
Ray Dalio 106,243 sh (+113.53%)
CI Can Am Small Cap 59,255 sh (+0.56%)
George Soros Sold Out
Paul Tudor Jones Sold Out
Jeremy Grantham Sold Out
Charles Brandes 177,421 sh (-2.42%)
Westport Asset Management 255,300 sh (-8.00%)
Jim Simons 83,382 sh (-57.28%)
David Rolfe 5,075 sh (-83.99%)
» More
Q2 2016

VAR Guru Trades in Q2 2016

Paul Tudor Jones 7,408 sh (New)
John Rogers 23,467 sh (New)
First Eagle Investment 4,325,749 sh (+35.30%)
Leucadia National Sold Out
Jim Simons Sold Out
Joel Greenblatt Sold Out
David Rolfe Sold Out
Westport Asset Management 250,300 sh (-1.96%)
Charles Brandes 169,029 sh (-4.73%)
Ray Dalio 44,400 sh (-58.21%)
» More
Q3 2016

VAR Guru Trades in Q3 2016

Richard Pzena 2,998 sh (New)
Steven Cohen 10,500 sh (New)
Jim Simons 11,500 sh (New)
Columbia Wanger 398,000 sh (New)
Paul Tudor Jones 8,463 sh (+14.24%)
John Rogers 24,968 sh (+6.40%)
Ray Dalio Sold Out
First Eagle Investment 4,316,310 sh (-0.22%)
Charles Brandes 156,511 sh (-7.41%)
CI Can Am Small Cap 52,355 sh (-11.64%)
» More
Q4 2016

VAR Guru Trades in Q4 2016

Joel Greenblatt 337,618 sh (New)
John Hussman 10,000 sh (New)
Paul Tudor Jones 18,666 sh (+120.56%)
Charles Brandes 163,536 sh (+4.49%)
First Eagle Investment 4,318,060 sh (+0.04%)
Steven Cohen Sold Out
Jim Simons Sold Out
Richard Pzena 2,860 sh (-4.60%)
Columbia Wanger 333,900 sh (-16.11%)
John Rogers 20,100 sh (-19.50%)
» More
» Details

Insider Trades

Latest Guru Trades with VAR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 334510    SIC: 3844
Compare:NYSE:TFX, NAS:ALGN, OTCPK:SONVY, OTCPK:SDMHF, OTCPK:CHEOY, OTCPK:CNVVY, NAS:ABMD, NAS:NUVA, NAS:MASI, OTCPK:FSPKF, OTCPK:EKTAY, NAS:IART, OTCPK:GGNDF, NAS:WMGI, NYSE:NVRO, NYSE:GMED, NYSE:PEN, NAS:LIVN, NAS:ZLTQ, OTCPK:SNNUF » details
Traded in other countries:VNM.Germany,
Varian Medical Systems Inc manufactures medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Varian Medical Systems Inc is a Delaware corporation originally incorporated in the year 1948 as Varian Associates, Inc. The Company manufactures medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. It is a supplier of x-ray imaging components for medical, scientific, and industrial applications and also supplies x-ray imaging products for cargo screening and industrial inspection. The Company has two reportable operating segments: Oncology Systems and Imaging Components. The Oncology Systems business segment designs, manufactures, sells and services hardware and software products for treating cancer with radiotherapy, stereotactic radiotherapy, stereotactic body radiotherapy, stereotactic radiosurgery and brachytherapy. Products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment and accessories; as well as information management, treatment planning and image processing software. Oncology Systems products enable radiation oncology departments in hospitals and clinics to perform conventional radiotherapy treatments and offer treatments such as fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy and stereotactic radiotherapy, as well as to treat patients using brachytherapy techniques, which involve temporarily implanting radioactive sources. The Company's Oncology Systems products are also used by neurosurgeons to perform stereotactic radiosurgery. Oncology Systems customers include university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices and cancer care clinics. The Imaging components business segment designs, manufactures, sells and services x-ray imaging components for use in a range of applications, including radiographic or fluoroscopic imaging, mammography, special procedures, computed tomography and industrial applications. The Company's x-ray imaging components are sold to large imaging system OEM customers that incorporate them into their medical diagnostic, dental, veterinary and industrial imaging systems. It sells x-ray tubes and flat panel digital image detectors for filmless x-ray imaging to small OEMs, independent service companies and directly to end-users for replacement purposes. The Company has three other businesses that are reported together under the Other category. The Company's imaging components business designs, manufactures, sells and services Linatron x-ray accelerators, imaging processing software and image detection products for security and inspection purposes, such as cargo screening at ports and borders and nondestructive examination in a variety of applications. The VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, a form of external beam radiotherapy using p

Guru Investment Theses on Varian Medical Systems Inc

Wedgewood Partners Comments on Varian Medical Systems - Jan 18, 2016

We sold Varian Medical Systems (NYSE:VAR) early in the quarter. The Company maintains its position as the dominant supplier of radiotherapy equipment and software, worldwide. We see Varian’s core business growing earnings per share at a steady, low to mid-single digit rate, as developed markets have reached maturity. In addition, the dramatic devaluation of the Japanese yen relative to the U.S. Dollar has caused some competitive pressures in its non-core Imaging and Components segment, further pressuring growth. While Imaging Components might regain competitiveness over the next few years, we do not think it will be enough to drive earnings growth to our required rate.



From Wedgewood Partners' fourth quarter 2015 client letter.



Check out David Rolfe latest stock trades

Top Ranked Articles about Varian Medical Systems Inc

The 'Bribing the Purchasing Agent Model' - Part I How to apply Charlie Munger's model
Charlie Munger (Trades, Portfolio) had famously asked this question to business school students: “Under what circumstances the correct answer for raising product volumes is to increase the price.” Very few students came up with luxury goods – higher prices indicate higher quality which in turn, leads to great sales. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 23.82
VAR's P/E(ttm) is ranked higher than
55% of the 172 Companies
in the Global Medical Devices industry.

( Industry Median: 25.50 vs. VAR: 23.82 )
Ranked among companies with meaningful P/E(ttm) only.
VAR' s P/E(ttm) Range Over the Past 10 Years
Min: 10.77  Med: 18.35 Max: 33.49
Current: 23.82
10.77
33.49
Forward P/E 19.96
VAR's Forward P/E is ranked higher than
64% of the 56 Companies
in the Global Medical Devices industry.

( Industry Median: 23.92 vs. VAR: 19.96 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 23.82
VAR's PE(NRI) is ranked higher than
54% of the 168 Companies
in the Global Medical Devices industry.

( Industry Median: 25.48 vs. VAR: 23.82 )
Ranked among companies with meaningful PE(NRI) only.
VAR' s PE(NRI) Range Over the Past 10 Years
Min: 9.86  Med: 18.19 Max: 33.49
Current: 23.82
9.86
33.49
Price/Owner Earnings (ttm) 47.26
VAR's Price/Owner Earnings (ttm) is ranked lower than
71% of the 103 Companies
in the Global Medical Devices industry.

( Industry Median: 30.29 vs. VAR: 47.26 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
VAR' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 13.91  Med: 21.29 Max: 49.49
Current: 47.26
13.91
49.49
P/B 4.53
VAR's P/B is ranked lower than
65% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 3.17 vs. VAR: 4.53 )
Ranked among companies with meaningful P/B only.
VAR' s P/B Range Over the Past 10 Years
Min: 2.71  Med: 4.49 Max: 9.09
Current: 4.53
2.71
9.09
P/S 2.48
VAR's P/S is ranked higher than
59% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 3.29 vs. VAR: 2.48 )
Ranked among companies with meaningful P/S only.
VAR' s P/S Range Over the Past 10 Years
Min: 1.43  Med: 2.57 Max: 4.74
Current: 2.48
1.43
4.74
PFCF 27.44
VAR's PFCF is ranked higher than
51% of the 106 Companies
in the Global Medical Devices industry.

( Industry Median: 27.61 vs. VAR: 27.44 )
Ranked among companies with meaningful PFCF only.
VAR' s PFCF Range Over the Past 10 Years
Min: 12.87  Med: 19.89 Max: 42.52
Current: 27.44
12.87
42.52
POCF 22.09
VAR's POCF is ranked lower than
60% of the 135 Companies
in the Global Medical Devices industry.

( Industry Median: 18.12 vs. VAR: 22.09 )
Ranked among companies with meaningful POCF only.
VAR' s POCF Range Over the Past 10 Years
Min: 10.2  Med: 15.97 Max: 33.14
Current: 22.09
10.2
33.14
EV-to-EBIT 15.04
VAR's EV-to-EBIT is ranked higher than
67% of the 169 Companies
in the Global Medical Devices industry.

( Industry Median: 21.48 vs. VAR: 15.04 )
Ranked among companies with meaningful EV-to-EBIT only.
VAR' s EV-to-EBIT Range Over the Past 10 Years
Min: 6  Med: 12 Max: 21.2
Current: 15.04
6
21.2
EV-to-EBITDA 12.85
VAR's EV-to-EBITDA is ranked higher than
59% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 15.79 vs. VAR: 12.85 )
Ranked among companies with meaningful EV-to-EBITDA only.
VAR' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.5  Med: 10.8 Max: 19.4
Current: 12.85
5.5
19.4
PEG 6.26
VAR's PEG is ranked lower than
79% of the 76 Companies
in the Global Medical Devices industry.

( Industry Median: 2.33 vs. VAR: 6.26 )
Ranked among companies with meaningful PEG only.
VAR' s PEG Range Over the Past 10 Years
Min: 0.67  Med: 1.18 Max: 9.42
Current: 6.26
0.67
9.42
Shiller P/E 24.26
VAR's Shiller P/E is ranked higher than
86% of the 49 Companies
in the Global Medical Devices industry.

( Industry Median: 49.62 vs. VAR: 24.26 )
Ranked among companies with meaningful Shiller P/E only.
VAR' s Shiller P/E Range Over the Past 10 Years
Min: 19.34  Med: 25.27 Max: 42.61
Current: 24.26
19.34
42.61
Current Ratio 1.59
VAR's Current Ratio is ranked lower than
75% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 2.45 vs. VAR: 1.59 )
Ranked among companies with meaningful Current Ratio only.
VAR' s Current Ratio Range Over the Past 10 Years
Min: 1.38  Med: 1.86 Max: 2.33
Current: 1.59
1.38
2.33
Quick Ratio 1.15
VAR's Quick Ratio is ranked lower than
72% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 1.79 vs. VAR: 1.15 )
Ranked among companies with meaningful Quick Ratio only.
VAR' s Quick Ratio Range Over the Past 10 Years
Min: 1.04  Med: 1.48 Max: 1.87
Current: 1.15
1.04
1.87
Days Inventory 129.10
VAR's Days Inventory is ranked higher than
51% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 130.88 vs. VAR: 129.10 )
Ranked among companies with meaningful Days Inventory only.
VAR' s Days Inventory Range Over the Past 10 Years
Min: 75.59  Med: 97.51 Max: 129.1
Current: 129.1
75.59
129.1
Days Sales Outstanding 90.76
VAR's Days Sales Outstanding is ranked lower than
69% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 66.78 vs. VAR: 90.76 )
Ranked among companies with meaningful Days Sales Outstanding only.
VAR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 85.76  Med: 90.38 Max: 105.45
Current: 90.76
85.76
105.45
Days Payable 34.72
VAR's Days Payable is ranked lower than
73% of the 254 Companies
in the Global Medical Devices industry.

( Industry Median: 58.05 vs. VAR: 34.72 )
Ranked among companies with meaningful Days Payable only.
VAR' s Days Payable Range Over the Past 10 Years
Min: 32.23  Med: 38.92 Max: 41.88
Current: 34.72
32.23
41.88

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 4.20
VAR's 3-Year Average Share Buyback Ratio is ranked higher than
98% of the 199 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. VAR: 4.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
VAR' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -3.5  Med: 1.3 Max: 4.5
Current: 4.2
-3.5
4.5

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 16.92
VAR's Price/Net Current Asset Value is ranked lower than
79% of the 234 Companies
in the Global Medical Devices industry.

( Industry Median: 6.59 vs. VAR: 16.92 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
VAR' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 6.53  Med: 11.23 Max: 39.93
Current: 16.92
6.53
39.93
Price/Tangible Book 5.86
VAR's Price/Tangible Book is ranked lower than
63% of the 283 Companies
in the Global Medical Devices industry.

( Industry Median: 4.24 vs. VAR: 5.86 )
Ranked among companies with meaningful Price/Tangible Book only.
VAR' s Price/Tangible Book Range Over the Past 10 Years
Min: 3.2  Med: 5.79 Max: 10.54
Current: 5.86
3.2
10.54
Price/Projected FCF 1.50
VAR's Price/Projected FCF is ranked higher than
69% of the 123 Companies
in the Global Medical Devices industry.

( Industry Median: 2.11 vs. VAR: 1.50 )
Ranked among companies with meaningful Price/Projected FCF only.
VAR' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.85  Med: 1.34 Max: 3.92
Current: 1.5
0.85
3.92
Price/DCF (Earnings Based) 1.67
VAR's Price/DCF (Earnings Based) is ranked higher than
64% of the 22 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. VAR: 1.67 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 0.96
VAR's Price/Median PS Value is ranked higher than
56% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 0.99 vs. VAR: 0.96 )
Ranked among companies with meaningful Price/Median PS Value only.
VAR' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.61  Med: 1.07 Max: 1.83
Current: 0.96
0.61
1.83
Price/Graham Number 2.49
VAR's Price/Graham Number is ranked lower than
58% of the 139 Companies
in the Global Medical Devices industry.

( Industry Median: 2.06 vs. VAR: 2.49 )
Ranked among companies with meaningful Price/Graham Number only.
VAR' s Price/Graham Number Range Over the Past 10 Years
Min: 0.66  Med: 2.35 Max: 4.04
Current: 2.49
0.66
4.04
Earnings Yield (Greenblatt) (%) 6.60
VAR's Earnings Yield (Greenblatt) (%) is ranked higher than
84% of the 337 Companies
in the Global Medical Devices industry.

( Industry Median: -0.30 vs. VAR: 6.60 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
VAR' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 4.7  Med: 8.4 Max: 16.8
Current: 6.6
4.7
16.8
Forward Rate of Return (Yacktman) (%) 6.62
VAR's Forward Rate of Return (Yacktman) (%) is ranked lower than
58% of the 123 Companies
in the Global Medical Devices industry.

( Industry Median: 8.88 vs. VAR: 6.62 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
VAR' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 6.6  Med: 19.5 Max: 28.8
Current: 6.62
6.6
28.8

More Statistics

Revenue (TTM) (Mil) $3,224
EPS (TTM) $ 3.51
Beta0.82
Short Percentage of Float7.04%
52-Week Range $67.23 - 94.48
Shares Outstanding (Mil)93.45

Analyst Estimate

Sep17 Sep18
Revenue (Mil $) 3,066 3,123
EPS ($) 4.19 4.55
EPS w/o NRI ($) 4.19 4.55
EPS Growth Rate
(3Y to 5Y Estimate)
9.08%
Dividends Per Share ($)
» More Articles for VAR

Headlines

Articles On GuruFocus.com
Columbia Wanger's Largest Trades in 3rd Quarter Nov 11 2016 
The 'Bribing the Purchasing Agent Model' – Part II Jul 12 2016 
The “Bribing the Purchasing Agent Model" - Part I Jul 11 2016 
First Eagle Investment Boosts Stake in American Express May 06 2016 
7 High Quality Guru Stocks Apr 11 2016 
David Rolfe Sells More Than 98% of 4 Stakes in His Portfolio Mar 10 2016 
David Rolfe Sells Coach, Alphabet Mar 09 2016 
Wedgewood Partners Comments on Varian Medical Systems Jan 18 2016 
Wedgewood Partners 4th Quarter Client Letter: 'Back to Our Regularly Scheduled Stock Market' Jan 15 2016 
David Rolfe Trims Holdings in Alphabet, Visa in 3rd Quarter Nov 24 2015 

More From Other Websites
What Makes Varian Medical (VAR) a Strong Sell? Feb 15 2017
VARIAN MEDICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission... Feb 14 2017
Moving Average Crossover Alert: Varian Medical Systems (VAR) Feb 14 2017
Varian (VAR) Eclipse Software Named Category Leader by KLAS Feb 14 2017
Varian (VAR) Wins Competitive Bid for Six Shanghai Hospitals Feb 13 2017
Varian Medical Systems Eclipse Treatment Planning Software Named Category Leader in the 2017 Best in... Feb 13 2017
VARIAN MEDICAL SYSTEMS INC Financials Feb 11 2017
Varian Advanced Radiotherapy Technology and Software Selected By Six Hospitals in Shanghai Feb 09 2017
Here's How Health-Care Reform Will Affect This Cancer Care Company Feb 07 2017
VARIAN MEDICAL SYSTEMS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Feb 07 2017
ETFs with exposure to Varian Medical Systems, Inc. : February 2, 2017 Feb 02 2017
VARIAN MEDICAL SYSTEMS INC Files SEC form 8-K/A, Financial Statements and Exhibits Feb 02 2017
Treatments Commence with Varian TrueBeam Systems at New London Hospital Jan 31 2017
The Hot Stock: Varex Imaging Jumps 7.3% Jan 30 2017
Varex Imaging Completes Separation From Varian Medical Systems, Lists On The Nasdaq Stock Market Jan 30 2017
Varian Announces Successful Separation of Imaging Components Business Jan 30 2017
Varian Medical Systems, Inc. :VAR-US: Earnings Analysis: Q1, 2017 By the Numbers : January 27, 2017 Jan 27 2017
Varian Medical (VAR) Misses on Q1 Earnings and Revenues Jan 26 2017
Edited Transcript of VAR earnings conference call or presentation 25-Jan-17 10:00pm GMT Jan 26 2017
Varian misses Street 1Q forecasts Jan 25 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)